Schneider Von Gunn Pharmaceuticals' Genesis Trial is open for enrolment.
The four-week clinical trial will investigate the efficacy of CBD oil for the management of abdominal pain from Irritable Bowel Syndrome (IBS), HERE.
THE Pharmaceutical Society of Australia (PSA) has announced the launch of its 2026 national conference, PSA26, under the theme ‘Home of Pharmacists’, with registrations now open.
SLOWLY tapering off antidepressants, combined with psychological support, could help prevent depression relapse to a similar extent as remaining on antidepressants, according to a large review published in Lancet Psychiatry.
THE planned sale of Mayne Pharmaceuticals to US pharma company Cosette has been called off today, with Mayne providing Cosette with notice that it has terminated the scheme implementation deed due to Cosette’s breaches of the scheme.